GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks. Now they're getting on his nerves. The post These 2 former stock market darlings ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

With a rich background in brand positioning, Laura brings a wealth of strategic experience partnering with renowned organizations including Keurig Dr Pepper, Nestle, American Cancer Society, Merck, ...

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Gilead Sciences, Inc. GILD reported better-than-expected third-quarter results and raised its annual earnings guidance.

By enhancing DEI strategies, UK firms can set themselves apart, fostering inclusivity that drives growth – Reshma Sheikh explains As major US firms like Harley Davidson, Brown-Forman and Molson Coors ...

The Clorox Company (NYSE: CLX) announced a strategic partnership with Manufacture 2030, or M2030, to help Clorox's suppliers ...

Dr. Fryhofer: The new ACIP vote only applies to MenB vaccination. There are two MenB vaccines, one by GSK, brand name BEXSERO and the other by Wyeth, which is a Pfizer subsidiary, with brand name ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

Yan Mei is a fugitive who is thought to reside in China. "Renopharma…attempted to re-brand GSK products under development as Renopharma products and attempted to sell them for billions of ...